ZGN-1061

Content sourced from Wikipedia, licensed under CC BY-SA 3.0.

ZGN-1061 is an experimental drug from Zafgen aimed at treating obesity and type 2 diabetes. It works in a similar way to Beloranib, an earlier drug, but was hoped to be safer. However, its development was stopped due to safety concerns.